The Yazen model, which integrates modern medication, lifestyle changes, and psychological support through a digital platform, has successfully treated over 30,000 patients. Recent data presented by Yazen at the ECO conference, including an oral presentation and two poster sessions, highlights the positive outcomes of this approach. A study of 2,008 patients revealed the following average weight loss over time:
8.3% after 3 months
12.9% after 6 months
16.4% after 12 months
16.6% after 18 months
A significant portion of the patients reached their target weight during the study and continued to focus on maintaining healthy habits for long-term weight management. The study also found that women experienced more weight loss than men on average, with women losing 17.6% and men 13.4% after 18 months. In addition to weight loss, notable improvements were observed in blood pressure, blood lipids, blood sugar levels, and liver function.
In another study based on data from 25,824 patients, it was found that 70% of patients remained on medication and continued the Yazen model after 12 months. This figure is significantly higher than results shown in other published studies.
“The results confirm that our digital model not only supports lasting weight loss but also enhances metabolic health. By combining personalized medication, lifestyle support, and ongoing follow-up, we’ve created a sustainable care model for those dealing with obesity and overweight,” said Martin Carlsson, co-founder and medical director at Yazen.
Personalized Care Leading to Fewer Side Effects and Better Outcomes
A key factor behind Yazen’s success is its approach to personalized care. While other healthcare providers often increase medication doses to the highest level, Yazen continuously adjusts doses based on each patient’s needs. This method reduces side effects, lowers medication costs, and improves overall patient well-being.
Patients receive the exact dose needed to manage hunger, achieve satiety, and improve their quality of life, without paying for more medication than necessary. This personalized approach has led to a high level of patient retention, with 70% staying in the program after 12 months and 60% after two years. The results demonstrate that long-term engagement with Yazen, alongside lifestyle support, creates favorable conditions for achieving sustainable weight loss. Even as medication doses can be gradually reduced, patients continue to benefit from lifestyle guidance.
A New Standard in Obesity Treatment
Obesity is a chronic condition requiring ongoing, multidisciplinary care. The Yazen model incorporates:
A personal doctor and health coach (nurse, dietitian, or physiotherapist)
Individualized medication with modern anti-obesity drugs
Psychological support for patients facing eating disorders or emotional challenges
An educational program and a digital community for motivation and support
This model ensures flexible, accessible, and continuous care via a digital platform, giving patients the best opportunity for lasting lifestyle changes.
“Patients who receive the right combination of medication, lifestyle support, and digital care are far more likely to succeed in their weight loss efforts. It’s time to shift the way we approach overweight and obesity treatment, tailoring care to meet each patient’s specific needs,” concluded Carlsson.
